Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)

CNY 37.71

(-1.33%)

Revenue Summary of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest annual revenue in 2023 was 932.12 Million CNY , up 37.76% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 310.32 Million CNY , up 23.01% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a annual revenue of 676.6 Million CNY in annual revenue 2022, up 37.06% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a annual revenue of 493.64 Million CNY in annual revenue 2021, up 42.12% from previous year.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a quarterly revenue of 252.26 Million CNY for 2024 Q1, up 5.06% from previous quarter.
  • Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported a quarterly revenue of 353.2 Million CNY for 2024 Q3, up 13.82% from previous quarter.

Annual Revenue Chart of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Historical Annual Revenue of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (2023 - 2017)

Year Revenue Revenue Growth
2023 932.12 Million CNY 37.76%
2022 676.6 Million CNY 37.06%
2021 493.64 Million CNY 42.12%
2020 347.35 Million CNY 48.74%
2019 233.52 Million CNY 73.24%
2018 134.79 Million CNY 273.91%
2017 36.04 Million CNY 0.0%

Peer Revenue Comparison of Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 90.345%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 67.966%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 98.766%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 93.923%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 89.092%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 88.041%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 88.664%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -373.563%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 96.169%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -64.859%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 94.4%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -44.521%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 82.759%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY -8.269%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 88.649%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 50.217%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 23.377%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 83.124%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 93.96%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 91.029%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 19.356%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 75.039%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 71.852%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -80.719%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 66.445%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 80.851%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -60.694%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 94.781%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 87.781%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY -10.265%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 90.79%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 90.881%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 29.526%
China National Medicines Corporation Ltd. 49.69 Billion CNY 98.124%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 91.014%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 70.297%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -116.276%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -968.088%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 48.548%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY -28.143%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -219.307%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 78.46%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 70.284%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 79.111%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 34.944%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 97.748%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 77.722%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 42.764%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 69.898%
Guobang Pharma Ltd. 5.34 Billion CNY 82.575%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -38.51%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 80.876%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 92.963%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 57.194%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 54.968%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 75.461%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 76.29%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 92.188%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -158.74%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 69.894%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY -1.279%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -38.785%
CanSino Biologics Inc. 345.18 Million CNY -170.037%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 57.126%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 84.835%